Biosynex SA
EPA:ALBIO.PA
2.88 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -35.61 | 15.614 | 104.004 | 31.37 | 1.098 | 0.543 | 0.315 | -0.12 | -0.364 | -1.529 | -1.758 |
| Depreciation & Amortization
| 13.459 | 16.368 | 6.613 | 6.641 | 0.552 | 0.467 | 0.485 | 0.49 | 0.462 | 0 | 0 |
| Deferred Income Tax
| -1.995 | -0.338 | 0.504 | 0.202 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 12.514 | -37.261 | 0.578 | -7.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 14.509 | -37.261 | 0.578 | -7.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 6.458 | 43.298 | 11.361 | 13.889 | -1.098 | -0.543 | -0.315 | 0.12 | 0.364 | 1.529 | 1.758 |
| Operating Cash Flow
| -9.654 | 4.945 | 109.835 | 31.637 | 1.104 | 0.467 | 0.485 | 0.49 | 0.462 | 0 | 0 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -39.544 | -30.08 | -19.015 | -9.118 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| -16.052 | 0.052 | 0.042 | 1.191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.706 | -9.054 | -9.988 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -54.813 | -39.082 | -28.962 | -7.926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | -0 | 19.426 | 4.448 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -3.219 | -1.732 | -20.082 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -20.443 | -1.936 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.808 | 23.451 | 33.818 | 12.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 5.171 | -10.814 | 14.396 | 10.617 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0.09 | -0.073 | 2.508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -59.296 | -44.86 | 95.196 | 34.985 | 0.001 | -0.168 | 1.419 | -0.456 | 0.462 | 0 | 0 |
| Cash At End Of Period
| 20.168 | 87.172 | 132.032 | 36.836 | 1.851 | 1.85 | 2.018 | 0.599 | 1.055 | 0 | 0 |